Location History:
- Bentleyville, OH (US) (2002)
- Seattle, WA (US) (2004)
Company Filing History:
1 out of 17 
1 out of 832,912 Years Active: 2002-2004
Title: Innovations by Robert C A Frederickson
Introduction
Robert C A Frederickson is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biomedical engineering, particularly in the area of fibrosis and cell invasion inhibition. With a total of two patents to his name, Frederickson's work has the potential to impact surgical procedures and healing processes.
Latest Patents
Frederickson's latest patents focus on methods and compositions based on the inhibition of cell invasion and fibrosis by anionic polymers. His research has led to the discovery that biocompatible anionic polymers can effectively inhibit fibrosis, scar formation, and surgical adhesions. The effectiveness of these polymers correlates with their anionic charge density. The invention provides a variety of materials for use in methods aimed at inhibiting fibrosis and fibroblast invasion. Notable anionic polymers include natural proteoglycans, glycosaminoglycan moieties, dextran sulfate, and pentosan polysulfate. The invention also offers compositions and methods to inhibit glial cell invasion, detrimental bone growth, and neurite outgrowth.
Career Highlights
Frederickson has worked with notable companies, including Gliatech, Inc. His career reflects a commitment to advancing medical technologies and improving patient outcomes through innovative solutions.
Collaborations
Some of his coworkers include Dikla Roufa and Adrian Harel, who have contributed to his research endeavors.
Conclusion
Robert C A Frederickson's innovative work in the field of biomedical engineering showcases his dedication to improving surgical outcomes and healing processes. His patents on anionic polymers represent a significant advancement in the fight against fibrosis and cell invasion.